Clinical Trials Browser

Has results × Glioma × Imatinib Mesylate × Clear all

NCT00049127 2019-10-21

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Phase 1/2 Completed

64 enrolled 11 charts

Brain Neoplasms, Glioma, Oligodendroglioma

NCT00290771 2011-05-16

Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Terminated

231 enrolled 12 charts

Glioblastoma, Glioma